放射線障害(放射線病、急性放射線症候群)の世界市場に関する洞察と2028年までの予測Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Insights and Forecast to 2028 市場の分析と洞察。放射線毒性(放射線病、急性放射線症候群)の世界市場 世界の放射線障害(放射線病、急性放射線症候群)市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー市場の分析と洞察。放射線毒性(放射線病、急性放射線症候群)の世界市場世界の放射線障害(放射線病、急性放射線症候群)市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間に年平均成長率(%)で推移する見込みです。 この健康危機による経済変化を十分に考慮し、2021年に放射線毒性(放射線病、急性放射線症候群)世界市場の%を占めた輸血は、2028年までに百万米ドルの価値を持ち、COVID-19後の期間に改訂された%のCAGRで成長すると予測されます。一方、病院セグメントは、この予測期間を通して%CAGRに変更されています。 中国放射線毒性(放射線病、急性放射線症候群)市場規模は2021年に百万米ドル、北米とヨーロッパ放射線毒性(放射線病、急性放射線症候群)はそれぞれ百万米ドル、百万米ドルと評価されています。北米の割合は2021年に%、中国とヨーロッパはそれぞれ%、%であり、中国の割合は2028年に%に達すると予測され、分析期間を通じてCAGRは%を推移しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%である。欧州の放射線毒性(放射線病、急性放射線症候群)については、ドイツが2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%である。 本レポートは、業界標準の分析精度と高いデータ整合性により、世界の放射線毒性(放射線障害、急性放射線症候群)市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得するのに役立つ素晴らしい試みとなっています。本レポートの購入者は、世界の放射線毒性(放射線障害、急性放射線症候群)市場の全体規模(収益ベース)を含む、検証済みで信頼できる市場予測にアクセスすることができます。 全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の放射線毒性(放射線病、急性放射線症候群)市場における持続的な成功を確保するために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。レポートを執筆したアナリストは、世界の放射線毒性(放射線病、急性放射線症候群)市場を詳細に調査するために、ユニークで業界最高の調査および分析アプローチをとりました。 世界の放射線毒性(放射線病、急性放射線症候群)の範囲と市場規模 放射線障害(放射線病、急性放射線症候群)市場は、プレイヤー別、地域(国)別、タイプ別、用途別に分類されます。世界の放射線毒性(放射線病、急性放射線症候群)市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして使用することで、優位に立つことができるようになるでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の収益と予測に焦点を当てています。 タイプ別セグメント 輸血 抗生物質 その他 用途別セグメント 病院 クリニック 会社別 アイオロス・ファーマシューティカルズ・インク アトックスバイオリミテッド BCNバイオサイエンシズLLC セルファイア・インク 第一三共株式会社 ファーストストリングリサーチインク RxBio社 シャトル・ファーマシューティカルズ LLC 地域別 北米 米国 カナダ 欧州 ドイツ フランス イギリス イタリア ロシア 北欧諸国 その他の欧州地域 アジア太平洋地域 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア ラテンアメリカ メキシコ ブラジル ラテンアメリカの残りの地域 中近東・アフリカ トルコ サウジアラビア UAE MEAの残りの地域 目次1 Report Business Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Blood Transfusion 1.2.3 Antibiotic 1.2.4 Others 1.3 Market by Application 1.3.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Perspective (2017-2028) 2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Growth Trends by Region 2.2.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Region (2017-2022) 2.2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Region (2023-2028) 2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Dynamics 2.3.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Industry Trends 2.3.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers 2.3.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges 2.3.4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Revenue 3.1.1 Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Revenue (2017-2022) 3.1.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Players (2017-2022) 3.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue 3.4 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio 3.4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue in 2021 3.5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Key Players Head office and Area Served 3.6 Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Solution and Service 3.7 Date of Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Type 4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Type (2017-2022) 4.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Type (2023-2028) 5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Application 5.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Application (2017-2022) 5.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028) 6.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type 6.2.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) 6.2.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) 6.2.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028) 6.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application 6.3.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) 6.3.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) 6.3.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028) 6.4 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country 6.4.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022) 6.4.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028) 7.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type 7.2.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) 7.2.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) 7.2.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028) 7.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application 7.3.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) 7.3.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) 7.3.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028) 7.4 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country 7.4.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022) 7.4.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028) 8.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type 8.2.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028) 8.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application 8.3.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028) 8.4 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region 8.4.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028) 9.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type 9.2.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) 9.2.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) 9.2.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028) 9.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application 9.3.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) 9.3.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) 9.3.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028) 9.4 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country 9.4.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022) 9.4.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028) 10.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type 10.2.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028) 10.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application 10.3.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028) 10.4 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country 10.4.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Aeolus Pharmaceuticals, Inc. 11.1.1 Aeolus Pharmaceuticals, Inc. Company Details 11.1.2 Aeolus Pharmaceuticals, Inc. Business Overview 11.1.3 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.1.4 Aeolus Pharmaceuticals, Inc. Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.1.5 Aeolus Pharmaceuticals, Inc. Recent Developments 11.2 Atox Bio Ltd 11.2.1 Atox Bio Ltd Company Details 11.2.2 Atox Bio Ltd Business Overview 11.2.3 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.2.4 Atox Bio Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.2.5 Atox Bio Ltd Recent Developments 11.3 BCN Biosciences LLC 11.3.1 BCN Biosciences LLC Company Details 11.3.2 BCN Biosciences LLC Business Overview 11.3.3 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.3.4 BCN Biosciences LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.3.5 BCN Biosciences LLC Recent Developments 11.4 Cellphire Inc 11.4.1 Cellphire Inc Company Details 11.4.2 Cellphire Inc Business Overview 11.4.3 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.4.4 Cellphire Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.4.5 Cellphire Inc Recent Developments 11.5 Daiichi Sankyo Co Ltd 11.5.1 Daiichi Sankyo Co Ltd Company Details 11.5.2 Daiichi Sankyo Co Ltd Business Overview 11.5.3 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.5.4 Daiichi Sankyo Co Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.5.5 Daiichi Sankyo Co Ltd Recent Developments 11.6 FirstString Research Inc 11.6.1 FirstString Research Inc Company Details 11.6.2 FirstString Research Inc Business Overview 11.6.3 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.6.4 FirstString Research Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.6.5 FirstString Research Inc Recent Developments 11.7 RxBio Inc 11.7.1 RxBio Inc Company Details 11.7.2 RxBio Inc Business Overview 11.7.3 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.7.4 RxBio Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.7.5 RxBio Inc Recent Developments 11.8 Shuttle Pharmaceuticals LLC 11.8.1 Shuttle Pharmaceuticals LLC Company Details 11.8.2 Shuttle Pharmaceuticals LLC Business Overview 11.8.3 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.8.4 Shuttle Pharmaceuticals LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.8.5 Shuttle Pharmaceuticals LLC Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
SummaryMarket Analysis and Insights: Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Table of Contents1 Report Business Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Blood Transfusion 1.2.3 Antibiotic 1.2.4 Others 1.3 Market by Application 1.3.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Perspective (2017-2028) 2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Growth Trends by Region 2.2.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Region (2017-2022) 2.2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Region (2023-2028) 2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Dynamics 2.3.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Industry Trends 2.3.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers 2.3.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges 2.3.4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Revenue 3.1.1 Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Revenue (2017-2022) 3.1.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Players (2017-2022) 3.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue 3.4 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio 3.4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue in 2021 3.5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Key Players Head office and Area Served 3.6 Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Solution and Service 3.7 Date of Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Type 4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Type (2017-2022) 4.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Type (2023-2028) 5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Application 5.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Application (2017-2022) 5.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028) 6.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type 6.2.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) 6.2.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) 6.2.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028) 6.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application 6.3.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) 6.3.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) 6.3.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028) 6.4 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country 6.4.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022) 6.4.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028) 7.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type 7.2.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) 7.2.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) 7.2.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028) 7.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application 7.3.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) 7.3.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) 7.3.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028) 7.4 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country 7.4.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022) 7.4.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028) 8.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type 8.2.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028) 8.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application 8.3.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028) 8.4 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region 8.4.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028) 9.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type 9.2.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) 9.2.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) 9.2.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028) 9.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application 9.3.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) 9.3.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) 9.3.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028) 9.4 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country 9.4.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022) 9.4.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2017-2028) 10.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type 10.2.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2017-2028) 10.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application 10.3.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2017-2028) 10.4 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country 10.4.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Aeolus Pharmaceuticals, Inc. 11.1.1 Aeolus Pharmaceuticals, Inc. Company Details 11.1.2 Aeolus Pharmaceuticals, Inc. Business Overview 11.1.3 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.1.4 Aeolus Pharmaceuticals, Inc. Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.1.5 Aeolus Pharmaceuticals, Inc. Recent Developments 11.2 Atox Bio Ltd 11.2.1 Atox Bio Ltd Company Details 11.2.2 Atox Bio Ltd Business Overview 11.2.3 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.2.4 Atox Bio Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.2.5 Atox Bio Ltd Recent Developments 11.3 BCN Biosciences LLC 11.3.1 BCN Biosciences LLC Company Details 11.3.2 BCN Biosciences LLC Business Overview 11.3.3 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.3.4 BCN Biosciences LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.3.5 BCN Biosciences LLC Recent Developments 11.4 Cellphire Inc 11.4.1 Cellphire Inc Company Details 11.4.2 Cellphire Inc Business Overview 11.4.3 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.4.4 Cellphire Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.4.5 Cellphire Inc Recent Developments 11.5 Daiichi Sankyo Co Ltd 11.5.1 Daiichi Sankyo Co Ltd Company Details 11.5.2 Daiichi Sankyo Co Ltd Business Overview 11.5.3 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.5.4 Daiichi Sankyo Co Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.5.5 Daiichi Sankyo Co Ltd Recent Developments 11.6 FirstString Research Inc 11.6.1 FirstString Research Inc Company Details 11.6.2 FirstString Research Inc Business Overview 11.6.3 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.6.4 FirstString Research Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.6.5 FirstString Research Inc Recent Developments 11.7 RxBio Inc 11.7.1 RxBio Inc Company Details 11.7.2 RxBio Inc Business Overview 11.7.3 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.7.4 RxBio Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.7.5 RxBio Inc Recent Developments 11.8 Shuttle Pharmaceuticals LLC 11.8.1 Shuttle Pharmaceuticals LLC Company Details 11.8.2 Shuttle Pharmaceuticals LLC Business Overview 11.8.3 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction 11.8.4 Shuttle Pharmaceuticals LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2017-2022) 11.8.5 Shuttle Pharmaceuticals LLC Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(中枢神経系作用薬)の最新刊レポート
QYResearch社の中枢神経系作用薬分野での最新刊レポート
本レポートと同じKEY WORD(acute)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |